Novel chemotherapy approaches in chemoradiation protocols

Gynecologic Oncology

Volumn 110, Issue 3 SUPPL.2, 2008, Pages

  González Cortijo, Lucía ^a   Carballo, N ^a   Gonzalez Martin A ^a   Corraliza, V ^a   Chiva de Agustin L ^a   Lapuente Sastre, F ^a   Garcia Garcia J F ^a   Rojo Sebastian A ^a   Hornedo, J ^a   Colomer, R ^a  

^a M D Anderson International España ^*  (Spain)

Author keywords

Cervix; Chemoradiation; Locally advanced

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CELECOXIB; CETUXIMAB; CISPLATIN; ERLOTINIB; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; MITOMYCIN; NAVELBINE; NEDAPLATIN; PACLITAXEL; SORAFENIB; TOPOTECAN;

ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG FATALITY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; HYSTERECTOMY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 50049130428     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.010     Document Type: Article

References (23)

1. Peters III W.A., Liu P.Y., Barrett R.J., et al. Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study. J Clin Oncol 18 (2000) 1606-1613
2. Keys H.M., Bundy B.M., Stehman F.B., et al. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. N Engl J Med 340 (1999) 1154-1161
3. Whitney C.W., Sause W., Bundy B.N., et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
4. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med 340 (1999) 1137-1143
5. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study. N Engl J Med 340 (1999) 1144-1153
6. National Cancer Institute: Clinical Announcement: Concurrent Chemoradiation for Cervical Cancer. Washington, DC: United States Department of Public Health, February 1999.
7. Thomas G., Dembo A., Ackerman I., et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 69 (1998) 137-145
8. Lanciano R., Calkins A., Bundy B.N., et al. A randomized comparison of weekly cisplatin or protracted venous infusion fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study. J Clin Oncol 23 (2005) 8289-8295
9. Corn B.W., Hernandez E., Anderson L., et al. Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: an interim report. Am J Clin Oncol 19 (1996) 317-321
10. Muderspach L., Curtin J.P., Roman L.D., et al. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol 65 (1997) 336-342
11. Micheletti E., LaFace B., Bianchi E., et al. Continuous infusion of carboplatin during conventional radiotherapytreatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC): a phase I/II and pharmacokinetic study. Am J Clin Oncol 20 (1997) 613-620
12. Higgins R.V., Naumann W.R., Hall J.B., et al. Concurrent weekly carboplatin with radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 89 (2003) 499-503
13. Yoshinaga K., Niikura H., Ogawa Y., et al. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 104 (2007) 36-40
14. Boualga K, Aksil N, Ayad M, et al. Phase I/II study of Gemcitabine and concomitant radiotherapy in locally advanced carcinoma of the cervix. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16s, Part I of II (June Supplement), 2005: 5142.
15. Bhatt ML, Matin A, Srivastava M, et al. Evaluation of Gemcitabine versus Cisplatinumas an adjunct to radiotherapy in locally advanced carcinoma of the uterine cervix. Journal of the Clinical Oncology, 2007 ASCO Annual Meeting Proceedings. Vol 25, No 18S, Part I. (June 20 Supplement), 2007: 16012.
16. Rao G., Rogres P., Coleman R., et al. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol Oncol 96 (2005) 168-172
17. Lee M.Y., Wu H.G., Kim K., et al. Concurrent radiotherapy with pclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol 106 (2007) 95-99
18. Gaffney D.K., Haslam D., Tsodikov A., et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56 4 (2003) 922-928
19. Activation 8/11/06, RTOG home.
20. Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer. ClinicalTrials.gov ID: NCT00104910].
21. Gafffney D., Winter K., Dicker A., et al. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with Celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Biol Oncol Phys 69 (2007) 111-117
22. A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer [recruiting.ClinicalTrials.gov].
23. Erlotinib Combined With Cisplatin and Radiotherapy for Patients With Locally Advanced Squamous Cell Cervical Cancer: A Phase II Trial. ASCO 2008. [Abstract 5511].